HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Romagnoli, P. Articles by van Meerwijk, J. P. M. Search for Related Content PubMed PubMed Citation Articles by Romagnoli, P. Articles by van Meerwijk, J. P. M.

Preferential Recognition of Self Antigens Despite Normal Thymic Deletion of CD4⁺CD25⁺ Regulatory T Cells¹

Paola Romagnoli^2,*, Denis Hudrisier^*, and Joost P. M. van Meerwijk^*,,

^* Institut National de la Santé et de la Recherche Médicale, Claude de Preval Institute, Purpan Hospital, Toulouse, France; Faculty of Life Sciences, University Toulouse III, Toulouse, France; and Institut Universitaire de France, Paris, France

	Abstract

Top Abstract Introduction Materials and Methods Results Discussion References

 
T cell tolerance to self Ags is in part established in the thymus by induction of apoptosis or anergy of potentially autoreactive thymocytes. Some autospecific T cells nevertheless migrate to peripheral lymphoid organs but are kept under control by the recently identified CD4⁺CD25⁺ regulatory T cell subset. Because these cells inhibit autoimmunity more efficiently than useful non-self Ag-specific immune responses, they are probably autospecific, posing important questions as to how they develop in the thymus. In this study we show that significantly more peripheral CD4⁺CD25⁺ regulatory T cells recognize self than non-self Ags. However, we also show for a large panel of endogenous superantigens as well as for self peptide/MHC complexes that autospecific CD4⁺CD25⁺ thymocyte precursors are normally deleted during ontogeny. Combined, our data firmly establish that the repertoire of regulatory T cells is specifically enriched in autospecific cells despite the fact that their precursors are normally susceptible to thymic deletion.

	Introduction

Top Abstract Introduction Materials and Methods Results Discussion References

 
Tolerance of T lymphocytes to self MHC-peptide ligands was thought to be mainly established by thymic deletion of developing autospecific T cells (1). Indeed, in absence of thymic deletion by APCs in bone marrow chimeras, 2- to 3-fold more mature T cells develop (2). Part of these autospecific cells are rendered anergic in the thymus upon recognition of self MHC/peptide ligands expressed by thymic epithelial cells (3). In transgenic mice expressing MHC/peptide complexes in the thymus exclusively on thymic cortical epithelial cells, a T cell repertoire develops that is strongly autoreactive in vitro and in vivo (4, 5, 6). However, total elimination of induction of T cell tolerance to self Ags still may not have been achieved in these transgenic mice because lethal graft-vs-host disease in syngeneic animals has not been observed and/or reported (our unpublished results). A third tolerance mechanism originating in the thymus is probably involved in this phenomenon: active (or "dominant") tolerance assured by regulatory T cells (7, 8, 9).

The critical role of active T cell tolerance is known from a variety of experimental systems (reviewed in Refs. 7, 8, 9, 10, 11). Rats rendered lymphopenic by thymectomy and split dose irradiation develop autoimmune thyroiditis and diabetes because of absence of regulatory T cells (12, 13). When reconstituted with CD4⁺CD45RB^high (but not CD4⁺ or CD4⁺CD45RB^low) T cells, athymic rats develop dispersed pathologic lesions (14). SCID mice that had received CD4⁺CD45RB^high cells developed colitis, whereas coadministration of CD4⁺CD45RB^low cells inhibited intestinal immunopathology (15, 16). Neonatal thymectomy causes severe autoimmunity, the precise target organ depending on the mouse strain used. The absence of CD4⁺CD25⁺ regulatory T cells in thymectomized mice appears to be responsible for the autoimmune manifestations (17). It has recently become clear that the T cells regulating intestinal inflammation have the same CD25⁺ phenotype as those inhibiting autoimmunity (18). CD4⁺CD25⁺ regulatory T cells are involved not only in the inhibition of autoimmunity and intestinal immunopathology but also in the occasional incapacity of T cells to eliminate tumors (19) as well as in tolerance to allogeneic grafts induced under cover of anti-CD4, -CD11a, -CD40 ligand, -CD25, or -CD3 Ab or CTLA4-Ig treatment (11, 20). Combined with reports on deletional and nondeletional peripheral tolerance (1), these data emphasize the redundancy in intra- and extrathymic T cell tolerance mechanisms as well as the major role of regulatory T cells in the control of pathological and physiological immunity.

In vivo data suggest that regulatory T cells are specific for Ags expressed on the target organ. Regulatory T cells can, upon transfer into lymphopenic or neonatally thymectomized animals, inhibit disease. However, when regulatory cells were derived from animals lacking ovaries, testes, prostate, or thyroid gland (male/female, surgical removal, radioactive iodine), tissue-specific autoimmunity could not be inhibited (or was inhibited less efficiently) (reviewed in Ref. 9). Interestingly, thyroid-specific regulatory T cells were found in the thymus but not among peripheral T cells in athyroid rats (21), indicating that regulatory T cells require interaction with Ag for their extrathymic survival.

Only sparse data are available concerning thymic selection of regulatory T cells. Their probable exclusively intrathymic origin has been suggested in the neonatal thymectomy-induced autoimmunity model (17). Moreover, thymocytes are known to be more efficient autoimmunity inhibitors than peripheral T cells (reviewed in Ref. 22). In neonatally mouse mammary tumor virus SW-infected BALB/c mice, the number of superantigen-specific V6⁺CD25⁺ thymocytes was increased, suggesting that interaction of thymocytes with agonist ligands favors differentiation of regulatory T cells (23). In mice doubly transgenic for influenza hemagglutinin (HA)³ and an I-E^d-restricted HA-specific TCR, large numbers of CD4⁺CD25⁺ T cells developed (24), indicating a role for agonist ligands in thymic development of regulatory T cells. Because normal developing thymocytes are deleted or rendered anergic upon recognition of (self) Ag, these two reports raise important questions as to how regulatory T cells develop in the thymus.

We have analyzed the frequency of CD4⁺CD25⁺ T cells recognizing self and non-self (allogeneic) MHC/peptide complexes expressed by professional APCs. Our data establish that, although among normal CD4⁺ T lymphocytes many more cells are specific for allogeneic than for syngeneic MHC/peptide ligands, the specificity of regulatory CD4⁺CD25⁺ cells is strongly biased toward self Ags. To analyze the responsible mechanism(s), we have assessed thymic deletion of CD4⁺CD25⁺ thymocyte precursors specific for a large panel of endogenous superantigens. Moreover, using bone marrow chimeras lacking MHC/peptide ligand expression on professional APCs (and therefore deficient in thymic deletion (2)), we have analyzed deletion of MHC/peptide complex-specific CD4⁺CD25⁺ thymocyte precursors. In both systems, perfectly normal thymic deletion of regulatory T cell precursors was observed. Therefore, the high frequency of mature autospecific regulatory T cells is, paradoxically, not caused by resistance to thymic deletion.

	Materials and Methods

Top Abstract Introduction Materials and Methods Results Discussion References

 
Mice

C57BL/6 and DBA/2 mice were purchased from Janvier (Le Genest St. Isle, France). C57BL/6 mice deficient in MHC expression (MHC°) (2) because of targeted deletions in the ₂-microglobulin and IA^b genes (25) were from Centre de Développement des Techniques Avancées-CentreNational de la Recherche Scientifique (Orléans, France). All experiments involving animals were performed in compliance with the relevant laws and institutional guidelines (IFR3O approval no. 31-13).

Abs

The following Abs and secondary reagents were used for phenotypic analysis: FITC- and biotin-labeled anti-TCR; FITC-labeled anti-TCR V2, -3, -4, -5.1/5.2, -6, -7, -8.1/8.2, -8.3, -9, -10^b, -11, -12, -13, -14, and -17^a; anti-CD25 PE (BD PharMingen, Heidelberg, Germany); FITC-labeled anti-CD4 (GK1.5); Red 613-labeled anti-CD4 and anti-CD8 (Life Technologies, Cergy Poutoise, France); and streptavidin tricolor (Caltag Laboratories, Burlingame, CA).

Flow cytometry

Thymi were homogenized, washed in PBS, 2.5% FCS, and 0.02% NaN₃, incubated with saturating concentrations of Ab for 20 min on ice, and washed before analysis using an Epics XL (Coulter, Marseille, France) or a FACSCalibur (BD Biosciences, San Jose, CA). Data were analyzed using WinMDI 2.8 (http://facs.scripps.edu/software.html) or CellQuest (BD Biosciences) software. For TCR V analysis, pooled thymocytes of three mice were depleted of CD8⁺ cells by treatment with anti-CD8 mAb 31 M (26) and complement (Saxon Europe, Suffolk, U.K.), followed by Lympholyte-M gradient (Cedarlane Laboratories, Hornby, Canada).

Bone marrow chimeras

Irradiation bone marrow chimeras were generated as previously described (2). In brief, anti-NK1.1 Ab-treated hosts (100 µg of PK136 (27) i.p. at days -1 and 0 of reconstitution) were lethally irradiated (850 rad gamma) using a ¹³⁷Cs source (700 rad/min) and the next day were reconstituted by retro-orbital i.v. injection of 8–15 x 10⁶ bone marrow cells that had been depleted of T cells and NK1.1⁺ cells using anti-Thy1 Ab AT83 (28) and PK136 plus C (Saxon Europe). Chimeras were kept on antibiotic-containing drinking water (0.2% bactrim; Roche, Basel, Switzerland) for the complete duration of the experiment (6 wk). Bone marrow chimeras were sublethally irradiated (600 rad gamma, ¹³⁷Cs, 700 rad/min) 4 wk after reconstitution. Thymi were analyzed by flow cytometry at day 15 postsublethal irradiation.

Limiting dilution analysis

C57BL/6 splenocytes were purified on Lympholyte M gradient (Cedarlane Laboratories). CD8⁺ and MHC class II⁺ cells were depleted using anti-CD8 Ab 53.6.7 (29), anti-MHC class II Ab M5/114 (30), and anti-rat IgG-coated magnetic beads (Dynal Biotech, Oslo, Norway). Remaining cells were stained with PE-labeled anti-CD25 mAb PC61 (BD PharMingen) and FITC-conjugated anti-CD4 mAb GK1.5 (31). CD4⁺CD25⁺ and CD4⁺CD25^- cells were electronically sorted (Coulter Epics Altra) into round-bottom 96-well plates (48 wells/condition) containing 5 x 10⁵ T cell-depleted (anti-Thy1 Ab AT83 (28) plus C) irradiated (3000 rad gamma) C57BL/6, B10.Q, or MHC° splenocytes in supplemented DMEM glutamax (Life Technologies) containing 100 U/ml IL-2 (supernatant of PMA-stimulated EL4.IL-2 cells (32); American Type Culture Collection, Manassas, VA) and 10% complement-free FCS. Cultures were assessed for proliferation 11 days later by flow cytometry in which a fixed volume of each culture was analyzed for the number of live CD4⁺ cells. Cultures were scored as positive if the number of CD4⁺ cells was superior to the mean ± SD of 24 control cultures containing the same number of T cells and MHC° APCs. Precursor frequencies were calculated as previouslydescribed (33).

	Results

Top Abstract Introduction Materials and Methods Results Discussion References

 
The peripheral regulatory T cell population contains a higher frequency of autospecific than alloreactive cells

We analyzed the frequency of regulatory T cells specific for autoantigens and alloantigens presented by APCs. Although regulatory T cells do not proliferate upon in vitro stimulation in absence of cytokines, in presence of high concentrations of IL-2 their "anergic" state can be transiently reversed (23) without loss of suppressive activity (34). Therefore, we performed limiting dilution analysis of normal and regulatory peripheral T cells stimulated with syngeneic, allogeneic, or MHC-deficient APCs in presence of 100 U/ml IL-2 (Fig. 1). The wells in which T cells were stimulated with MHC° APCs were used to establish the baseline above which proliferation (as assessed by FACS analysis, as previously described (35)) was considered to be positive (see Materials and Methods). Although, as expected among CD4⁺CD25^- T cells, a significantly higher frequency of alloreactive than autoreactive cells was consistently observed, among CD4⁺CD25⁺ cells the frequency of autoreactive cells was reproducibly and significantly higher than that of alloreactive cells (Fig. 1 and Table I). Similar results were obtained for mature CD4⁺CD25⁺ vs CD4⁺CD25^- thymocytes (data not shown). Because the plating efficiencies of CD25^- and CD25⁺ cells are probably not identical (despite the addition of high concentrations of IL-2), no direct comparison between the frequencies of B6-reactive CD25^- and CD25⁺ cells should be made. These data indicate that the repertoire of regulatory T lymphocytes is strongly enriched in autospecific cells, which appears consistent with their critical role in the inhibition of autoimmunity.

View larger version (19K): [in this window] [in a new window]   FIGURE 1. Higher frequency of regulatory T cells specific for self than for non-self MHC/peptide ligands. CD4+CD8-CD25- or CD4+CD8-CD25+ splenocytes were electronically sorted into 96-well plates containing C57BL/6 or B10.Q APCs in an IL-2-rich culture medium. Eleven days later, FITC-labeled anti-CD4 mAb was added to each well and accumulation of CD4+ cells was analyzed by flow cytometry. A typical experiment is shown. f, Calculated precursor frequency.

To assess whether the high frequency of autospecific regulatory T cells results from a deficiency of thymic deletion of their precursors, we analyzed susceptibility of CD4⁺CD25⁺ regulatory T cell precursors to endogenous superantigen-mediated deletion. DBA/2 mice express Mtv 1, 6, 7, 8, 11, 13, 14, and 17 and therefore delete V3-, -5-, -6-, -7-, -8.1-, -9-, -11-, and -12-expressing thymocytes (36). Control animals were C57BL/6 mice that do not delete superantigen-specific thymocytes. Pooled thymocytes from three mice were depleted of CD8⁺ cells by complement-mediated lysis, and the remaining CD8^- cells were analyzed by flow cytometry using a panel of 15 Abs directed to distinct TCR-V regions. Significantly reduced percentages of V3-, -5-, -6-, -9-, and -12-expressing CD4⁺CD8^-CD25^- thymocytes were observed in DBA/2 mice compared with C57BL/6 controls (Fig. 2), whereas deletion of V7 and V11 was much less pronounced. Importantly, superantigen-specific CD4⁺CD8^-CD25⁺ thymocytes were depleted to the same extent as CD4⁺CD8^-CD25⁺ cells. These results indicate that precursors of CD4⁺CD25⁺ regulatory T cells are normally susceptible to superantigen-induced deletion.

View larger version (20K): [in this window] [in a new window]   FIGURE 2. Normal thymic deletion of endogenous superantigen-specific regulatory T cell precursors. The TCR-V repertoire of CD4+CD8-CD25- and CD4+CD8-CD25+ C57BL/6 (no superantigen-dependent deletion) and DBA/2 thymocytes was analyzed by flow cytometry using a panel of 15 V-specific Abs. Error bars indicate SD (n = 3). The anti-V17 Ab was used as negative control because C57BL/6 and DBA/2 mice do not contain a functional gene for this particular V region.

The majority, if not all, of thymic deletion depends on MHC/peptide complexes expressed by thymic APCs, in particular by dendritic cells (1, 37). In bone marrow chimeras expressing MHC/peptide complexes on radioresistant cells but not on cells of hematopoietic origin, a 2- to 3-fold increased generation of mature thymocytes was observed (2). To analyze whether precursors of regulatory CD4⁺CD25⁺ T cells are susceptible to deletion induced by self peptide/MHC ligands expressed by thymic APCs, we analyzed their generation in bone marrow chimeras.

Regulatory T cells are known to develop later than normal CD4⁺ cells during ontogeny. Therefore, we first compared kinetics of the development of regulatory vs normal mature CD4⁺ thymocytes in sublethally irradiated adult C57BL/6 animals. As shown in Fig. 3A, normal mature CD4⁺ thymocytes accumulated over a 1-wk period, from days 9 to 15 postirradiation. Surprisingly, CD4⁺CD25⁺ thymocytes developed simultaneously and with similar kinetics.

View larger version (17K): [in this window] [in a new window]   FIGURE 3. Normal thymic deletion of self-MHC/peptide complex-specific regulatory T cell precursors. A, Reconstitution of CD4+CD8-CD25- and CD4+CD8-CD25+ populations after sublethal gamma irradiation. Adult C57BL/6 mice were irradiated at 600 rad gamma, and their thymocytes were analyzed 9–15 days later by flow cytometry. Error bars indicate SD (n = 3). B, Increased generation of CD4+CD8-TCRhighCD25- (p < 0.005, Student’s t test) and CD4+CD8-TCRhighCD25+ (p < 0.02) thymocytes in MHC°C57BL/6 compared with C57BL/6C57BL/6 bone marrow chimeras. Bone marrow chimeras were sublethally irradiated 4 wk post-bone marrow reconstitution, and their thymi were analyzed by flow cytometry 15 days later. Error bars indicate SD (B6B6, n = 9; MHC°B6, n = 5).

	Discussion

Top Abstract Introduction Materials and Methods Results Discussion References

 
In this report, we show that the frequency of autospecific regulatory CD4⁺CD25⁺ T cells is higher than that of cells specific for allogeneic ligands. However, precursors of regulatory CD4⁺CD25⁺ T cells are susceptible to thymic deletion by professional APCs. Importantly, this result is valid for a large panel of superantigens deleting several different TCR V-expressing thymocytes, as well as for self peptide/MHC complexes. Therefore, in contrast to earlier suggestions, autospecific regulatory T cells preferentially develop despite susceptibility to thymic deletion.

The kinetics of development of regulatory and normal CD4⁺ T cells (in sublethally irradiated mice) were similar. This result is in contrast to the situation in neonates, in which CD4⁺CD25⁺ T cells develop at least 3 days later than normal CD4⁺ cells (17, 24). Therefore, precursors of regulatory T cells may arrive in the thymus later than precursors of normal T cells, but once in the thymus these two populations develop with similar kinetics. Alternatively, thymic stroma may generate specific conditions required for regulatory T cell differentiation starting at day 3 postbirth. In this respect, it would be of interest to combine adult precursor populations with fetal thymic stroma, e.g., in reaggregate cultures (38).

Our results indicating that normal and regulatory T cells develop with similar kinetics in sublethally irradiated animals may also appear to be in contrast to the results of Jordan et al. (24), who analyzed development of regulatory T cells in HA-specific TCR and HA doubly transgenic animals using BrdU incorporation. In adult doubly transgenic mice, BrdU⁺ regulatory T cells appeared with 50% slower kinetics than normal mature CD4⁺ thymocytes. The reasons for the discrepancy between those and our results are not clear, but it would suggest that normal and regulatory T cells are derived from different precursor populations in the thymus and that regulatory T cell precursors divide less frequently than normal thymocytes.

We show that regulatory T cell precursors specific for a large panel of endogenous superantigens are normally deleted in the thymus. These data are in contrast to the increased accumulation of V6-expressing CD4⁺CD25⁺ thymocytes in mouse mammary tumor virus SW-infected BALB/c (as compared with uninfected) mice reported by Papiernik et al. (23). This discrepancy may be due to differences in the experimental systems used (endogenous vs exogenous superantigens) and/or in the superantigen expression pattern.

In TCR-transgenic mice, CD25⁺ regulatory T cells express an endogenous TCR chain in addition to the transgenic one (39, 40). Therefore, even if regulatory T cells are equally sensitive to deletion induced by superantigens (which almost exclusively interact with TCR chains (36)), they might not be sensitive to MHC-peptide complex-mediated deletion (41, 42). However, our data show that significantly more regulatory T cells develop in absence than in presence of MHC/peptide complexes expressed by APCs of hematopoietic origin. These data confirm that regulatory T cell precursors are susceptible to thymic deletion. Increased (rather than decreased) differentiation of CD4⁺CD25⁺ thymocytes has been observed in doubly transgenic mice expressing an influenza HA S1 peptide/I-E^d-specific TCR as well as its agonist ligand (24), which would suggest their resistance to deletion. However, the low level of HA-transgene expression in the thymus has been reported to be limited to the cortical region (43), which is devoid of cells capable of inducing deletion in vivo (3, 4, 6). The transgenic HA expression patterns and/or levels in three other HA-transgenic mouse lines induced deletion rather than development of transgenic S1/I-E^d TCR-expressing thymocytes (24). Whatever the precise explanation, our data clearly indicate for a large panel of superantigens as well as for the normal "repertoire" of self peptide/MHC complexes that autospecific regulatory T cell precursors are deleted in the thymus. Our data agree with and significantly extend recently published results concerning regulatory T cells developing in transgenic mice expressing MHC class II molecules exclusively on cortical epithelium. These cells appeared to be significantly more autoreactive than CD4⁺CD25⁺ cells developing in wt mice, indicating that medullary epithelium and/or APCs of bone marrow origin induce anergy and/or deletion-mediated self-tolerance in this T cell subset (44). It will be interesting to assess the relative contributions of medullary epithelium and APCs to the induction of regulatory T cell tolerance to self MHC/peptide ligands.

Despite normal thymic deletion of endogenous superantigen or self peptide/MHC-specific regulatory T cell precursors, a high frequency of self-specific CD4⁺CD25⁺ cells nevertheless leaves the thymus and populates the periphery. In our limiting dilution assay, more autoreactive than alloreactive regulatory T cells were reproducibly found. Therefore, the repertoire of regulatory T lymphocytes appears to be biased toward cells specific for self Ags, which could be explained by the recently reported positive selection of TCR-transgenic regulatory T cells in presence of agonist ligand (24). If confirmed, this could explain how regulatory T cells mainly inhibit autoimmunity, allowing useful immune responses to develop. Importantly, because only a part of self Ags is expressed by splenic APCs, the real frequency of autospecific regulatory T cells is probably even higher. Because thymic deletion by APCs normally applies to regulatory T cell precursors, the observed high frequency of autoreactivity reflects the level of autospecific precursors that either recognize their MHC/peptide ligand at the surface of cells incapable of apoptosis induction (e.g., thymic cortical (4, 6) and probably also medullary epithelium (3)) or do not encounter it at all in the thymus (e.g., tissue-specific Ags). If a normal precursor recognizes its ligand at the surface of medullary epithelium, it will be rendered anergic and this unresponsive state can only inefficiently be reversed by IL-2 (3). In contrast, the naturally anergic state of regulatory T cells can readily be reversed by IL-2 (23, 34). This probably explains how a high frequency of autospecific regulatory T cells can develop, despite normal susceptibility to thymic deletion.

Whatever the precise explanation, our data firmly establish that the repertoire of regulatory T lymphocytes is biased toward autospecific cells. However, in contrast to earlier proposed explanations for the proposed autospecificity, we showed in this study that regulatory T cell precursors are as susceptible to induction of deletion as are their normal counterparts. Combined with the earlier reported increased generation of autospecific regulatory T cells in presence of agonist ligand (24), our data indicate that thymic generation of these cells depends on recognition of an MHC/peptide ligand exclusively at the surface of thymic elements incapable of induction of deletion, i.e., thymic cortical and/or medullary epithelial cells (4, 6). Finally, our observation that significantly more regulatory T cells recognize self than non-self ligands would explain how these cells mainly inhibit autoimmunity, leaving useful non-self-specific immune responses to freely develop.

	Acknowledgments

 
We thank the staff of the animal facility of the Institut Claude de Preval for their excellent work, Rosemary Lees for her critical help with the limiting dilution analysis, and Georges Cassar for cell sorting.

	Footnotes

 
¹ This work was supported by the Association François Aupetit.

² Address correspondence and reprint requests to Dr. Paola Romagnoli, Institut National de la Santé et de la Recherche Médicale, Claude de Preval Institute, Purpan Hospital, U395, Institut Fédératif de Recherche 30, BP 3028, 31024 Toulouse Cedex 03, France. E-mail address: Paola.Romagnoli{at}toulouse.inserm.fr

³ Abbreviations used in this paper: HA, hemagglutinin; MHC°, MHC class I and II deficient; wt, wild type.

Received for publication August 29, 2001. Accepted for publication December 3, 2001.

	References

Top Abstract Introduction Materials and Methods Results Discussion References

 

1. Stockinger, B.. 1999. T lymphocyte tolerance: from thymic deletion to peripheral control mechanisms. Adv. Immunol. 71:229.[Medline]
2. van Meerwijk, J. P. M., S. Marguerat, R. K. Lees, R. N. Germain, B. J. Fowlkes, H. R. MacDonald. 1997. Quantitative impact of thymic clonal deletion on the T cell repertoire. J. Exp. Med. 185:377.[Abstract/Free Full Text]
3. Ramsdell, F., T. Lantz, B. J. Fowlkes. 1989. A nondeletional mechanism of thymic self tolerance. Science 246:1038.[Abstract/Free Full Text]
4. Laufer, T. M., J. DeKoning, J. S. Markowitz, D. Lo, L. H. Glimcher. 1996. Unopposed positive selection and autoreactivity in mice expressing class II MHC only on thymic cortex. Nature 383:81.[Medline]
5. Laufer, T. M., L. Fan, L. H. Glimcher. 1999. Self-reactive T cells selected on thymic cortical epithelium are polyclonal and are pathogenic in vivo. J. Immunol. 162:5078.[Abstract/Free Full Text]
6. Capone, M., P. Romagnoli, F. Beermann, H. R. MacDonald, J. P. M. van Meerwijk. 2001. Dissociation of thymic positive and negative selection in transgenic mice expressing major histocompatibility complex class I molecules exclusively on thymic cortical epithelial cells. Blood 97:1336.[Abstract/Free Full Text]
7. Sakaguchi, S.. 2000. Animal models of autoimmunity and their relevance to human diseases. Curr. Opin. Immunol. 12:684.[Medline]
8. Sakaguchi, S.. 2000. Regulatory T cells: key controllers of immunologic self-tolerance. Cell 101:455.[Medline]
9. Shevach, E. M.. 2000. Regulatory T cells in autoimmmunity. Annu. Rev. Immunol. 18:423.[Medline]
10. Le Douarin, N., C. Corbel, A. Bandeira, V. Thomas-Vaslin, Y. Modigliani, A. Coutinho, J. Salaun. 1996. Evidence for a thymus-dependent form of tolerance that is not based on elimination or anergy of reactive T cells. Immunol. Rev. 149:35.[Medline]
11. Waldmann, H., S. Cobbold. 1998. How do monoclonal antibodies induce tolerance? A role for infectious tolerance?. Annu. Rev. Immunol. 16:619.[Medline]
12. Penhale, W. J., P. A. Stumbles, C. R. Huxtable, R. J. Sutherland, D. W. Pethick. 1990. Induction of diabetes in PVG/c strain rats by manipulation of the immune system. Autoimmunity 7:169.[Medline]
13. Fowell, D., D. Mason. 1993. Evidence that the T cell repertoire of normal rats contains cells with the potential to cause diabetes: characterization of the CD4⁺ T cell subset that inhibits this autoimmune potential. J. Exp. Med. 177:627.[Abstract/Free Full Text]
14. Powrie, F., D. Mason. 1990. OX-22^highCD4⁺ T cells induce wasting disease with multiple organ pathology: prevention by the OX-22^low subset. J. Exp. Med. 172:1701.[Abstract/Free Full Text]
15. Powrie, F., R. Correa-Oliveira, S. Mauze, R. L. Coffman. 1994. Regulatory interactions between CD45RB^high and CD45RB^lowCD4⁺ T cells are important for the balance between protective and pathogenic cell-mediated immunity. J. Exp. Med. 179:589.[Abstract/Free Full Text]
16. Morrissey, P. J., K. Charrier, S. Braddy, D. Liggitt, J. D. Watson. 1993. CD4⁺ T cells that express high levels of CD45RB induce wasting disease when transferred into congenic severe combined immunodeficient mice: disease development is prevented by cotransfer of purified CD4⁺ T cells. J. Exp. Med. 178:237.[Abstract/Free Full Text]
17. Asano, M., M. Toda, N. Sakaguchi, S. Sakaguchi. 1996. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J. Exp. Med. 184:387.[Abstract/Free Full Text]
18. Read, S., V. Malmstrom, F. Powrie. 2000. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25⁺CD4⁺ regulatory cells that control intestinal inflammation. J. Exp. Med. 192:295.[Abstract/Free Full Text]
19. Shimizu, J., S. Yamazaki, S. Sakaguchi. 1999. Induction of tumor immunity by removing CD25⁺CD4⁺ T cells: a common basis between tumor immunity and autoimmunity. J. Immunol. 163:5211.[Abstract/Free Full Text]
20. Hara, M., C. I. Kingsley, M. Niimi, S. Read, S. E. Turvey, A. R. Bushell, P. J. Morris, F. Powrie, K. J. Wood. 2001. IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J. Immunol. 166:3789.[Abstract/Free Full Text]
21. Seddon, B., D. Mason. 1999. Peripheral autoantigen induces regulatory T cells that prevent autoimmunity. J. Exp. Med. 189:877.[Abstract/Free Full Text]
22. Saoudi, A., B. Seddon, V. Heath, D. Fowell, D. Mason. 1996. The physiological role of regulatory T cells in the prevention of autoimmunity: the function of the thymus in the generation of the regulatory T cell subset. Immunol. Rev. 149:195.[Medline]
23. Papiernik, M., M. L. de Moraes, C. Pontoux, F. Vasseur, C. Penit. 1998. Regulatory CD4 T cells: expression of IL-2R chain, resistance to clonal deletion and IL-2 dependency. Int. Immunol. 10:371.[Abstract/Free Full Text]
24. Jordan, M. S., A. Boesteanu, A. J. Reed, A. L. Petrone, A. E. Holenbeck, M. A. Lerman, A. Naji, A. J. Caton. 2001. Thymic selection of CD4⁺CD25⁺ regulatory T cells induced by an agonist self-peptide. Nat. Immunol. 2:301.[Medline]
25. Chan, S. H., D. Cosgrove, C. Waltzinger, C. Benoist, D. Mathis. 1993. Another view of the selective model of thymocyte selection. Cell 73:225.[Medline]
26. Sarmiento, M., D. P. Dialynas, D. W. Lancki, K. A. Wall, M. I. Lorber, M. R. Loken, F. W. Fitch. 1982. Cloned T lymphocytes and monoclonal antibodies as probes for cell surface molecules active in T cell-mediated cytolysis. Immunol. Rev. 68:135.[Medline]
27. Koo, G. C., J. R. Peppard. 1984. Establishment of monoclonal anti-Nk-1.1 antibody. Hybridoma 3:301.[Medline]
28. Sarmiento, M., M. R. Loken, F. W. Fitch. 1981. Structural differences in cell surface T25 polypeptides from thymocytes and cloned T cells. Hybridoma 1:13.[Medline]
29. Ledbetter, J. A., L. A. Herzenberg. 1979. Xenogeneic monoclonal antibodies to mouse lymphoid differentiation antigens. Immunol. Rev. 47:63.[Medline]
30. Bhattacharya, A., M. E. Dorf, T. A. Springer. 1981. A shared alloantigenic determinant on Ia antigens encoded by the I-A and I-E subregions: evidence for I region gene duplication. J. Immunol. 127:2488.[Abstract]
31. Dialynas, D. P., Z. S. Quan, K. A. Wall, A. Pierres, J. Quintans, M. R. Loken, M. Pierres, F. W. Fitch. 1983. Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule. J. Immunol. 131:2445.[Abstract]
32. Farrar, J. J., J. Fuller-Farrar, P. L. Simon, M. L. Hilfiker, B. M. Stadler, W. L. Farrar. 1980. Thymoma production of T cell growth factor (IL-2). J. Immunol. 125:2555.[Abstract]
33. Taswell, C.. 1981. Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis. J. Immunol. 126:1614.[Abstract]
34. Takahashi, T., Y. Kuniyasu, M. Toda, N. Sakaguchi, M. Itoh, M. Iwata, J. Shimizu, S. Sakaguchi. 1998. Immunologic self-tolerance maintained by CD25⁺CD4⁺ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int. Immunol. 10:1969.[Abstract/Free Full Text]
35. Dengler, T. J., D. R. Johnson, J. S. Pober. 2001. Human vascular endothelial cells stimulate a lower frequency of alloreactive CD8⁺ pre-CTL and induce less clonal expansion than matching B lymphoblastoid cells: development of a novel limiting dilution analysis method based on CFSE labeling of lymphocytes. J. Immunol. 166:3846.[Abstract/Free Full Text]
36. Luther, S. A., H. Acha-Orbea. 1997. Mouse mammary tumor virus: immunological interplays between virus and host. Adv. Immunol. 65:139.[Medline]
37. Anderson, G., N. C. Moore, J. J. T. Owen, E. J. Jenkinson. 1996. Cellular interactions in thymocyte development. Annu. Rev. Immunol. 14:73.[Medline]
38. Jenkinson, E. J., G. Anderson, J. J. Owen. 1992. Studies on T cell maturation on defined thymic stromal cell populations in vitro. J. Exp. Med. 176:845.[Abstract/Free Full Text]
39. Itoh, M., T. Takahashi, N. Sakaguchi, Y. Kuniyasu, J. Shimizu, F. Otsuka, S. Sakaguchi. 1999. Thymus and autoimmunity: production of CD25⁺CD4⁺ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J. Immunol. 162:5317.[Abstract/Free Full Text]
40. Thornton, A. M., E. M. Shevach. 2000. Suppressor effector function of CD4⁺CD25⁺ immunoregulatory T cells is antigen nonspecific. J. Immunol. 164:183.[Abstract/Free Full Text]
41. Elliott, J. I., D. M. Altmann. 1995. Dual T cell receptor chain T cells in autoimmunity. J. Exp. Med. 182:953.[Abstract/Free Full Text]
42. Zal, T., S. Weiss, A. Mellor, B. Stockinger. 1996. Expression of a second receptor rescues self-specific T cells from thymic deletion and allows activation of autoreactive effector function. Proc. Natl. Acad. Sci. USA 93:9102.[Abstract/Free Full Text]
43. Cerasoli, D. M., J. McGrath, S. R. Carding, F. F. Shih, B. B. Knowles, A. J. Caton. 1995. Low avidity recognition of a class II-restricted neo-self peptide by virus-specific T cells. Int. Immunol. 7:935.[Abstract/Free Full Text]
44. Bensinger, S. J., A. Bandeira, M. S. Jordan, A. J. Caton, T. M. Laufer. 2001. Major histocompatibility complex class II-positive cortical epithelium mediates the selection of CD4⁺25⁺ immunoregulatory T cells. J. Exp. Med. 194:427.[Abstract/Free Full Text]

This article has been cited by other articles:

				J. Larkin III, A. L. Rankin, C. C. Picca, M. P. Riley, S. A. Jenks, A. J. Sant, and A. J. Caton CD4+CD25+ Regulatory T Cell Repertoire Formation Shaped by Differential Presentation of Peptides from a Self-Antigen J. Immunol., February 15, 2008; 180(4): 2149 - 2157. [Abstract] [Full Text] [PDF]

				J. Ribot, G. Enault, S. Pilipenko, A. Huchenq, M. Calise, D. Hudrisier, P. Romagnoli, and J. P. M. van Meerwijk Shaping of the Autoreactive Regulatory T Cell Repertoire by Thymic Cortical Positive Selection J. Immunol., November 15, 2007; 179(10): 6741 - 6748. [Abstract] [Full Text] [PDF]

				R. Li, N. Perez, S. Karumuthil-Melethil, B. S. Prabhakar, M. J. Holterman, and C. Vasu Enhanced Engagement of CTLA-4 Induces Antigen-Specific CD4+CD25+Foxp3+ and CD4+CD25 TGF-beta1+ Adaptive Regulatory T Cells J. Immunol., October 15, 2007; 179(8): 5191 - 5203. [Abstract] [Full Text] [PDF]

				J. Andersson, I. Stefanova, G. L. Stephens, and E. M. Shevach CD4+CD25+ regulatory T cells are activated in vivo by recognition of self Int. Immunol., April 1, 2007; 19(4): 557 - 566. [Abstract] [Full Text] [PDF]

				S. R. J. Taylor, D. R. Alexander, J. C. Cooper, C. F. Higgins, and J. I. Elliott Regulatory T Cells Are Resistant to Apoptosis via TCR but Not P2X7 J. Immunol., March 15, 2007; 178(6): 3474 - 3482. [Abstract] [Full Text] [PDF]

				E. Kekalainen, H. Tuovinen, J. Joensuu, M. Gylling, R. Franssila, N. Pontynen, K. Talvensaari, J. Perheentupa, A. Miettinen, and T. P. Arstila A Defect of Regulatory T Cells in Patients with Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy J. Immunol., January 15, 2007; 178(2): 1208 - 1215. [Abstract] [Full Text] [PDF]

				B. Fritzsching, N. Oberle, E. Pauly, R. Geffers, J. Buer, J. Poschl, P. Krammer, O. Linderkamp, and E. Suri-Payer Naive regulatory T cells: a novel subpopulation defined by resistance toward CD95L-mediated cell death Blood, November 15, 2006; 108(10): 3371 - 3378. [Abstract] [Full Text] [PDF]

				J. Tellier, J. P. M. van Meerwijk, and P. Romagnoli An MHC-linked locus modulates thymic differentiation of CD4+CD25+Foxp3+ regulatory T lymphocytes Int. Immunol., November 1, 2006; 18(11): 1509 - 1519. [Abstract] [Full Text] [PDF]

				N. Bosco, F. Agenes, A. G. Rolink, and R. Ceredig Peripheral T Cell Lymphopenia and Concomitant Enrichment in Naturally Arising Regulatory T Cells: The Case of the Pre-T{alpha} Gene-Deleted Mouse J. Immunol., October 15, 2006; 177(8): 5014 - 5023. [Abstract] [Full Text] [PDF]

				J. Ribot, P. Romagnoli, and J. P. M. van Meerwijk Agonist Ligands Expressed by Thymic Epithelium Enhance Positive Selection of Regulatory T Lymphocytes from Precursors with a Normally Diverse TCR Repertoire J. Immunol., July 15, 2006; 177(2): 1101 - 1107. [Abstract] [Full Text] [PDF]

				M. Shimoda, F. Mmanywa, S. K. Joshi, T. Li, K. Miyake, J. Pihkala, J. A. Abbas, and P. A. Koni Conditional Ablation of MHC-II Suggests an Indirect Role for MHC-II in Regulatory CD4 T Cell Maintenance. J. Immunol., June 1, 2006; 176(11): 6503 - 6511. [Abstract] [Full Text] [PDF]

				P. Romagnoli, D. Hudrisier, and J. P. M. van Meerwijk Molecular Signature of Recent Thymic Selection Events on Effector and Regulatory CD4+ T Lymphocytes J. Immunol., November 1, 2005; 175(9): 5751 - 5758. [Abstract] [Full Text] [PDF]

				E. T. Samy, L. A. Parker, C. P. Sharp, and K. S.K. Tung Continuous control of autoimmune disease by antigen-dependent polyclonal CD4+CD25+ regulatory T cells in the regional lymph node J. Exp. Med., September 19, 2005; 202(6): 771 - 781. [Abstract] [Full Text] [PDF]

				C. Domenig, A. Sanchez-Fueyo, J. Kurtz, S. P. Alexopoulos, C. Mariat, M. Sykes, T. B. Strom, and X. X. Zheng Roles of Deletion and Regulation in Creating Mixed Chimerism and Allograft Tolerance Using a Nonlymphoablative Irradiation-Free Protocol J. Immunol., July 1, 2005; 175(1): 51 - 60. [Abstract] [Full Text] [PDF]

				G. Darrasse-Jeze, G. Marodon, B. L. Salomon, M. Catala, and D. Klatzmann Ontogeny of CD4+CD25+ regulatory/suppressor T cells in human fetuses Blood, June 15, 2005; 105(12): 4715 - 4721. [Abstract] [Full Text] [PDF]

				J. C. Ochando, A. C. Yopp, Y. Yang, A. Garin, Y. Li, P. Boros, J. Llodra, Y. Ding, S. A. Lira, N. R. Krieger, et al. Lymph Node Occupancy Is Required for the Peripheral Development of Alloantigen-Specific Foxp3+ Regulatory T Cells J. Immunol., June 1, 2005; 174(11): 6993 - 7005. [Abstract] [Full Text] [PDF]

				H. Kojima, Y. Kanno, H. Hase, and T. Kobata CD4+CD25+ Regulatory T Cells Attenuate the Phosphatidylinositol 3-Kinase/Akt Pathway in Antigen-Primed Immature CD8+ CTLs during Functional Maturation J. Immunol., May 15, 2005; 174(10): 5959 - 5967. [Abstract] [Full Text] [PDF]

				A. M. Hanash and R. B. Levy Donor CD4+CD25+ T cells promote engraftment and tolerance following MHC-mismatched hematopoietic cell transplantation Blood, February 15, 2005; 105(4): 1828 - 1836. [Abstract] [Full Text] [PDF]

				A. La Cava, F. M. Ebling, and B. H. Hahn Ig-Reactive CD4+CD25+ T Cells from Tolerized (New Zealand Black x New Zealand White)F1 Mice Suppress In Vitro Production of Antibodies to DNA J. Immunol., September 1, 2004; 173(5): 3542 - 3548. [Abstract] [Full Text] [PDF]

				S. P. Cobbold, R. Castejon, E. Adams, D. Zelenika, L. Graca, S. Humm, and H. Waldmann Induction of foxP3+ Regulatory T Cells in the Periphery of T Cell Receptor Transgenic Mice Tolerized to Transplants J. Immunol., May 15, 2004; 172(10): 6003 - 6010. [Abstract] [Full Text] [PDF]

				K. A. Kasow, X. Chen, J. Knowles, D. Wichlan, R. Handgretinger, and J. M. Riberdy Human CD4+CD25+ Regulatory T Cells Share Equally Complex and Comparable Repertoires with CD4+CD25- Counterparts J. Immunol., May 15, 2004; 172(10): 6123 - 6128. [Abstract] [Full Text] [PDF]

				M. Karim, C. I. Kingsley, A. R. Bushell, B. S. Sawitzki, and K. J. Wood Alloantigen-Induced CD25+CD4+ Regulatory T Cells Can Develop In Vivo from CD25-CD4+ Precursors in a Thymus-Independent Process J. Immunol., January 15, 2004; 172(2): 923 - 928. [Abstract] [Full Text] [PDF]

				A. Antov, L. Yang, M. Vig, D. Baltimore, and L. Van Parijs Essential Role for STAT5 Signaling in CD25+CD4+ Regulatory T Cell Homeostasis and the Maintenance of Self-Tolerance J. Immunol., October 1, 2003; 171(7): 3435 - 3441. [Abstract] [Full Text] [PDF]

S. Fisson, G. Darrasse-Jeze, E. Litvinova, F. S